Search - tctmd.com

Displaying 81 - 100 of 224

Sort: Relevancy | Date

Presentation TCT 2014

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn

September 13, 2014

Presentation TCT 2014

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Felix Mahfoud

September 13, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

Presentation TCT 2014

Affirmative: Time to Move On!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

Presentation

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Presenter: A. Persue

May 12, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

Advertisement

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Affirmative: Time to Move On!

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Renal Denervation Shows Promise in Patients Refractory to Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content